Advanced
  Home Compare Reports

Comparison with Similar Reports

Diagnostic Imaging Market by Product (MRI (Open, Closed), Ultrasound (2D, 4D, Doppler), CT, X-Ray (Digital, Analog), SPECT, Hybrid PET, Mammography), ...

Publisher:        MarketsandMarkets

# of Pages:        392

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 46
1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.2.1 INCLUSIONS & EXCLUSIONS 46
1.3 MARKETS SCOPE 47
1.3.1 MARKETS COVERED 47
1.3.2 YEARS CONSIDERED FOR THE STUDY 48
1.4 CURRENCY 49
TABLE 1 STANDARD CURRENCY CONVERSION RATES 49
1.5 LIMITATIONS 49
1.6 STAKEHOLDERS 49
1.7 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH DATA 51
FIGURE 1 DIAGNOSTIC IMAGING MARKET: RESEARCH METHODOLOGY STEPS 51
FIGURE 2 RESEARCH DESIGN 52
2.1.1 SECONDARY RESEARCH 52
2.1.1.1 Key data from secondary sources 53
2.1.2 PRIMARY RESEARCH 54
FIGURE 3 PRIMARY SOURCES 54
2.1.2.1 Key data from primary sources 55
2.1.2.2 Key industry insights 56
FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS:
BY COMPANY TYPE, DESIGNATION, AND REGION 56
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 57
2.2 MARKET SIZE ESTIMATION 57
2.2.1 PRODUCT-BASED MARKET ESTIMATION 58
2.2.2 VOLUME-BASED MARKET ESTIMATION 58
FIGURE 6 MARKET SIZE ESTIMATION: DIAGNOSTIC IMAGING MARKET 59
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 60
2.2.3 PRIMARY RESEARCH VALIDATION 60
2.3 COVID-19 HEALTH ASSESSMENT 61
2.4 COVID-19 ECONOMIC ASSESSMENT 61
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 62
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY 62
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 63
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE DIAGNOSTIC IMAGING MARKET 64
2.7 MARKET BREAKDOWN AND DATA TRIANGULATION 65
FIGURE 10 DIAGNOSTIC IMAGING MARKET: DATA TRIANGULATION METHODOLOGY 65
2.8 RESEARCH ASSUMPTIONS AND LIMITATIONS 66
2.8.1 ASSUMPTIONS FOR THE STUDY 66
2.9 RISK ASSESSMENT 67
TABLE 2 RISK ASSESSMENT: DIAGNOSTIC IMAGING MARKET 67
3 EXECUTIVE SUMMARY 68
FIGURE 11 DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 68
FIGURE 12 DIAGNOSTIC IMAGING MARKET, BY APPLICATION,
2021 VS 2026 (USD MILLION) 69
FIGURE 13 DIAGNOSTIC IMAGING MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 70
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE DIAGNOSTIC IMAGING MARKET 71
4 PREMIUM INSIGHTS 72
4.1 DIAGNOSTIC IMAGING: MARKET OVERVIEW 72
FIGURE 15 INCREASING GERIATRIC POPULATION AND SUBSEQUENT RISE IN ASSOCIATED DISEASES IS DRIVING MARKET GROWTH 72
4.2 DIAGNOSTIC IMAGING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 73
FIGURE 16 THE ULTRASOUND SYSTEMS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 73
4.3 EUROPE: DIAGNOSTIC IMAGING MARKET SHARE, BY PRODUCT AND COUNTRY, 2021 74
FIGURE 17 ULTRASOUND SYSTEMS TO DOMINATE THE DIAGNOSTIC IMAGING MARKET IN EUROPE 74
4.4 GEOGRAPHIC SNAPSHOT OF THE DIAGNOSTIC IMAGING MARKET 75
FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 19 DIAGNOSTIC IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76
5.2.1 DRIVERS 77
5.2.1.1 Growing geriatric population and the rising prevalence of associated diseases 77
TABLE 3 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES 77
5.2.1.2 Increasing demand for early diagnosis and widening scope of clinical applications 78
5.2.1.3 Technological advancements in diagnostic imaging modalities 78
TABLE 4 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING SYSTEMS 79
5.2.1.4 Increasing investments, funds, and grants by public-private organizations 80
TABLE 5 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET 80
5.2.2 RESTRAINTS 82
5.2.2.1 High cost of diagnostic imaging systems 82
5.2.2.2 Technological limitations associated with standalone systems 82
5.2.2.3 Declining reimbursements and increasing regulatory burden in
the US 82
TABLE 6 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007–2019 83
5.2.2.4 Shortage of helium 83
5.2.3 OPPORTUNITIES 84
5.2.3.1 Growth opportunities in emerging countries 84
5.2.3.2 Adoption of AI and analytics in diagnostic imaging 84
5.2.3.3 Use of blockchain in diagnostic imaging 85
5.2.3.4 Increasing adoption of teleradiology 86
5.2.3.5 Contract-based radiology solutions and mobile solutions 86
5.2.4 CHALLENGES 87
5.2.4.1 Hospital budget cuts 87
5.2.4.2 Increasing adoption of refurbished diagnostic imaging systems 87
5.2.4.3 Dearth of trained professionals 88
5.3 TRENDS & BURNING ISSUES 88
5.3.1 INCREASING ADOPTION OF HYBRID DIAGNOSTIC IMAGING MODALITIES 88
5.3.2 OVERUTILIZATION OF DIAGNOSTIC IMAGING SERVICES AROUND THE WORLD 89
5.4 PRICING ANALYSIS 90
TABLE 7 REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES, 2020 (USD) 90
5.5 VALUE CHAIN ANALYSIS 91
5.5.1 RESEARCH & DEVELOPMENT 91
5.5.2 MANUFACTURING & ASSEMBLY 91
5.5.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 91
FIGURE 20 VALUE CHAIN ANALYSIS 91
5.6 ECOSYSTEM ANALYSIS 92
5.7 SUPPLY CHAIN ANALYSIS 92
5.7.1 PROMINENT COMPANIES 92
5.7.2 SMALL & MEDIUM-SIZED ENTERPRISES 92
5.7.3 END USERS 92
FIGURE 21 SUPPLY CHAIN ANALYSIS 93
5.7.4 ROLE IN ECOSYSTEM 93
5.8 PORTER’S FIVE FORCES ANALYSIS 94
TABLE 8 DIAGNOSTIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 94
5.8.1 BARGAINING POWER OF BUYERS 94
5.8.2 BARGAINING POWER OF SUPPLIERS 94
5.8.3 THREAT OF NEW ENTRANTS 94
5.8.4 THREAT OF SUBSTITUTES 94
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 95
5.9 REGULATORY ANALYSIS 95
5.9.1 NORTH AMERICA 95
5.9.1.1 US 95
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 95
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 96
5.9.1.2 Canada 96
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 96
5.9.2 EUROPE 97
5.9.3 ASIA PACIFIC 97
5.9.3.1 Japan 97
TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 98
5.9.3.2 China 98
TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES 98
5.9.3.3 India 100
5.10 REIMBURSEMENT SCENARIO 100
TABLE 14 MEDICAL REIMBURSEMENT CODES FOR MRI PROCEDURES IN
THE US (AS OF 2021) 101
TABLE 15 MEDICAL REIMBURSEMENT CODES FOR CT IMAGING PROCEDURES IN
THE US (AS OF 2021) 102
TABLE 16 MEDICAL REIMBURSEMENT CODES FOR PET/CT IMAGING PROCEDURES IN THE US (AS OF 2021) 103
TABLE 17 MEDICAL REIMBURSEMENT CODES FOR ULTRASOUND IMAGING PROCEDURES IN THE US (AS OF 2021) 103
TABLE 18 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES IN THE US (AS OF 2021) 104
TABLE 19 MEDICAL REIMBURSEMENT CODES FOR RADIOLOGY PROCEDURES IN
THE US (AS OF 2021) 105
5.11 IMPACT OF COVID-19 ON THE DIAGNOSTIC IMAGING MARKET 107
5.11.1 PATENT ANALYSIS 109
FIGURE 22 MAJOR PATENT HOLDERS FOR ULTRASOUND IMAGING SYSTEMS
(JANUARY 2011-MAY 2021) 109
FIGURE 23 MAJOR PATENT HOLDERS FOR MRI SYSTEMS (JANUARY 2011-MAY 2021) 109
FIGURE 24 MAJOR PATENT HOLDERS FOR CT SCANNERS (JANUARY 2011-MAY 2021) 110
FIGURE 25 MAJOR PATENT HOLDERS FOR MAMMOGRAPHY SYSTEMS
(JANUARY 2011-MAY 2021) 110
FIGURE 26 MAJOR PATENT HOLDERS FOR NUCLEAR IMAGING SYSTEMS
(JANUARY 2011-MAY 2021) 111
FIGURE 27 MAJOR PATENT HOLDERS FOR X-RAY IMAGING SYSTEMS
(JANUARY 2011-MAY 2021) 111
FIGURE 28 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIAGNOSTIC IMAGING PATENTS, 2011–2021 112
5.12 TRADE ANALYSIS 112
5.12.1 TRADE ANALYSIS FOR COMPUTED TOMOGRAPHY SYSTEMS 112
5.12.1.1 Import Data for Computed Tomography Systems, by Country, 2016─2020 (USD Million) 112
5.12.1.2 Export Data for Computed Tomography Systems, by Country, 2016─2020 (USD Million) 113
5.12.2 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS 113
5.12.2.1 Import Data for Magnetic Resonance Imaging Systems, by Country, 2016─2020 (USD Million) 113
5.12.2.2 Export Data for Ultrasound Systems, by Country,
2016─2020 (USD Million) 114
5.12.3 TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 114
5.12.3.1 Import Data for Magnetic Resonance Imaging Systems, by Country, 2016─2020 (USD Million) 114
5.12.3.2 Export Data for Magnetic Resonance Imaging Systems, by Country, 2016─2020 (USD Million) 115
5.12.4 TRADE ANALYSIS FOR X- RAY SYSTEMS 115
5.12.4.1 Import Data for X-ray Systems, by Country,
2016─2020 (USD Million) 115
5.12.4.2 Export Data for X-ray Systems, by Country,
2016─2020 (USD Million) 116
6 DIAGNOSTIC IMAGING MARKET, BY PRODUCT 117
6.1 INTRODUCTION 118
TABLE 20 DIAGNOSTIC IMAGING MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 118
6.2 CT SCANNERS 118
TABLE 21 CT SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 119
TABLE 22 CT SCANNERS MARKET, BY REGION, 2019–2026 (UNITS) 119
TABLE 23 CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
6.2.1 CONVENTIONAL CT SCANNERS 120
TABLE 24 CONVENTIONAL CT SCANNERS MARKET, BY REGION,
2019–2026 (USD MILLION) 120
TABLE 25 CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
6.2.1.1 High-slice CT scanners 121
6.2.1.1.1 High imaging resolution and wide applications of high-slice scanners have made them popular among end users 121
TABLE 26 HIGH-SLICE CT SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 122
6.2.1.2 Mid-slice CT scanners 122
6.2.1.2.1 The affordability of mid-slice CT has driven its adoption in emerging markets 122
TABLE 27 MID-SLICE CT SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 123
6.2.1.3 Low-slice CT scanners 123
6.2.1.3.1 Low-slice CT scanners are being replaced with mid-slice CT systems 123
TABLE 28 LOW-SLICE CT SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 123
6.2.2 CONE-BEAM CT SCANNERS 124
6.2.2.1 Lower radiation exposure and increasing applications in dental and limb scanning have driven CBCT adoption 124
TABLE 29 CBCT SCANNERS MARKET, BY REGION, 2019–2026 (USD MILLION) 124
6.3 ULTRASOUND SYSTEMS 125
TABLE 30 ULTRASOUND SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 125
TABLE 31 ULTRASOUND SYSTEMS MARKET, BY REGION, 2019–2026 (UNITS) 125
6.3.1 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY 126
TABLE 32 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 126
6.3.1.1 2D ultrasound systems 126
6.3.1.1.1 2D ultrasound systems dominate the global ultrasound systems market 126
TABLE 33 2D ULTRASOUND SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 127
6.3.1.2 3D & 4D ultrasound systems 127
6.3.1.2.1 Technological advancements and potential are driving the demand for 3D & 4D ultrasound 127
TABLE 34 3D & 4D ULTRASOUND SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 128
6.3.1.3 Doppler ultrasound systems 128
6.3.1.3.1 While noninvasive, Doppler imaging can heat tissues being scanned 128
TABLE 35 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 129
6.3.2 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY 129
TABLE 36 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 130
6.3.2.1 Trolley/cart-based ultrasound systems 130
6.3.2.1.1 Wide applications and technological advancements in trolley/cart-based systems are driving market growth 130
TABLE 37 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 131
6.3.2.2 Compact/portable ultrasound systems 131
6.3.2.2.1 High portability and ease of use is contributing to the demand for compact systems 131
TABLE 38 COMPACT/PORTABLE ULTRASOUND SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 132
6.4 X-RAY IMAGING SYSTEMS 132
TABLE 39 X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 132
TABLE 40 X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (UNITS) 133
6.4.1 X-RAY IMAGING SYSTEMS MARKET, BY TYPE 133
TABLE 41 X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
6.4.1.1 Digital X-ray imaging systems 134
FIGURE 29 COMPUTED RADIOGRAPHY VS. DIRECT RADIOGRAPHY 134
TABLE 42 DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 135
TABLE 43 DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
6.4.1.1.1 Direct radiography systems 135
6.4.1.1.1.1 High-throughput capabilities and quick operations have propelled the demand for DR systems 135
TABLE 44 DIRECT RADIOGRAPHY SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 136
6.4.1.1.2 Computed radiography systems 136
6.4.1.1.2.1 CR technology is rapidly replacing analog systems acting in the emerging economies 136
TABLE 45 COMPUTED RADIOGRAPHY SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 137
6.4.1.2 Analog X-ray imaging systems 137
6.4.1.2.1 Higher risk of radiation exposure and technological limitations impede the market growth 137
TABLE 46 ANALOG X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 138
6.4.2 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY 138
TABLE 47 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 138
6.4.2.1 Stationary X-ray imaging systems 139
6.4.2.1.1 Greater integration of configurations makes stationary X-ray systems preferable in a diagnostic clinic 139
TABLE 48 STATIONARY X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 139
6.4.2.2 Portable X-ray imaging systems 139
6.4.2.2.1 Portable systems register high adoption in trauma care and emergency departments 139
TABLE 49 PORTABLE X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 140
6.5 MRI SYSTEMS 140
TABLE 50 MRI SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 140
TABLE 51 MRI SYSTEMS MARKET, BY REGION, 2019–2026 (UNITS) 141
6.5.1 MRI SYSTEMS MARKET, BY ARCHITECTURE 141
TABLE 52 MRI SYSTEMS MARKET, BY ARCHITECTURE, 2019–2026 (USD MILLION) 141
6.5.1.1 Closed MRI systems 142
6.5.1.1.1 Closed MRI systems are widely adopted across the globe 142
TABLE 53 CLOSED MRI SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 142
6.5.1.2 Open MRI systems 143
6.5.1.2.1 Open MRI can reduce anxiety in claustrophobic individuals 143
TABLE 54 OPEN MRI SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 143
6.5.2 MRI SYSTEMS MARKET, BY FIELD STRENGTH 143
TABLE 55 MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2019–2026 (USD MILLION) 144
6.5.2.1 High & very-high-field MRI systems 144
6.5.2.1.1 High & very-high-field MRI systems dominate the global MRI systems market 144
TABLE 56 HIGH & VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 145
6.5.2.2 Low-to-mid-field MRI systems 145
6.5.2.2.1 Technological limitations have reduced the adoption of low-to-mid-field MRI systems 145
TABLE 57 LOW-TO-MID-FIELD (<1.5T) SYSTEMS OFFERED IN THE MARKET 145
TABLE 58 LOW-TO-MID-FIELD SYSTEMS MRI SYSTEMS, BY REGION,
2019–2026 (USD MILLION) 146
6.5.2.3 Ultra-high-field MRI systems 146
6.5.2.3.1 Innovation and advancements in applications have supported the demand for ultra-high-field systems 146
TABLE 59 ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 147
6.6 NUCLEAR IMAGING SYSTEMS 147
TABLE 60 NUCLEAR IMAGING SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 147
TABLE 61 NUCLEAR IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (UNITS) 148
TABLE 62 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
6.6.1 SPECT SYSTEMS 148
TABLE 63 SPECT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 149
TABLE 64 SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
6.6.1.1 Hybrid SPECT systems 149
6.6.1.1.1 High cost and shortage of Technetium-99m have hindered market growth 149
TABLE 65 HYBRID SPECT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 150
6.6.1.2 Standalone SPECT systems 150
6.6.1.2.1 Low cost, technological advancements, and long radiotracer half-life have all contributed to market growth 150
TABLE 66 STANDALONE SPECT SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 151
6.6.2 HYBRID PET SYSTEMS 151
6.6.2.1 Hybrid PET systems hold greater prospects of dominating the nuclear imaging systems market 151
TABLE 67 HYBRID PET SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 152
6.7 MAMMOGRAPHY SYSTEMS 152
6.7.1 MAMMOGRAPHY SYSTEMS SEGMENT TO GROW AT THE HIGHEST CAGR 152
TABLE 68 MAMMOGRAPHY SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 153
TABLE 69 MAMMOGRAPHY SYSTEMS MARKET, BY REGION, 2019–2026 (UNITS) 153
7 DIAGNOSTIC IMAGING MARKET, BY APPLICATION 154
7.1 INTRODUCTION 155
7.2 X-RAY IMAGING SYSTEMS 155
FIGURE 30 GENERAL RADIOGRAPHY APPLICATIONS TO WITNESS THE HIGHEST GROWTH IN THE X-RAY IMAGING SYSTEMS MARKET DURING THE FORECAST PERIOD 155
TABLE 70 X-RAY IMAGING SYSTEMS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 155
7.2.1 GENERAL RADIOGRAPHY 156
7.2.1.1 General radiography applications account for the largest share of the X-ray imaging systems market 156
7.2.2 DENTISTRY 157
7.2.2.1 High prevalence of dental disorders to drive the growth of this application segment 157
7.2.3 FLUOROSCOPY 157
7.2.3.1 Product launches and approvals of fluoroscopy systems to support the growth of this application segment 157
7.3 MRI SYSTEMS 158
FIGURE 31 BRAIN & NEUROLOGICAL MRI SEGMENT HOLDS THE LARGEST SHARE OF
THE MRI SYSTEMS MARKET 158
TABLE 71 MRI SYSTEMS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 159
7.3.1 BRAIN & NEUROLOGICAL MRI 159
7.3.1.1 Brain & neurological MRI dominates the MRI systems market 159
7.3.2 SPINE & MUSCULOSKELETAL MRI 159
7.3.2.1 MRI is the most-preferred imaging method for the diagnosis and prognosis of MSK disorders and spinal injuries 159
7.3.3 VASCULAR MRI 160
7.3.3.1 Rising incidence of vascular disorders to drive the market for this application segment 160
7.3.4 PELVIC & ABDOMINAL MRI 160
7.3.4.1 Increasing incidence of pelvic & abdominal diseases to support market growth 160
7.3.5 BREAST MRI 160
7.3.5.1 Rising prevalence of breast cancer and increasing awareness about early breast cancer screening—key drivers for the breast MRI market 160
7.3.6 CARDIAC MRI 161
7.3.6.1 The rising incidence of CVD and technological advancements in cardiac MRI are the key factors supporting the growth of this application segment 161
7.4 ULTRASOUND SYSTEMS 161
FIGURE 32 VASCULAR APPLICATIONS SEGMENT WILL GROW AT THE HIGHEST CAGR IN THE ULTRASOUND SYSTEMS MARKET, BY APPLICATION 161
TABLE 72 ULTRASOUND SYSTEMS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 162
7.4.1 RADIOLOGY/GENERAL IMAGING 162
7.4.1.1 Radiology/general imaging is the largest application segment of the ultrasound market 162
7.4.2 OBSTETRICS/GYNECOLOGY 162
7.4.2.1 Increasing demand for minimally invasive techniques in gynecological diagnostic procedures to support market growth 162
7.4.3 CARDIOLOGY 163
7.4.3.1 Cardiology is one of the largest and most widely used ultrasound application segments 163
7.4.4 VASCULAR APPLICATIONS 163
7.4.4.1 Vascular ultrasound is one of the fastest-growing application segments for ultrasound technologies across major markets 163
7.4.5 UROLOGY 164
7.4.5.1 The rising incidence of prostate disorders & kidney stones will drive the market for this application segment 164
7.4.6 OTHER APPLICATIONS 164
7.5 CT SCANNERS 165
FIGURE 33 CARDIOLOGY SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE CT SCANNERS MARKET DURING THE FORECAST PERIOD 165
TABLE 73 CT SCANNERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 166
7.5.1 CARDIOLOGY 166
7.5.1.1 Cardiac CT is one of the largest and most widely used CT application segments across the globe 166
7.5.2 ONCOLOGY 167
7.5.2.1 The rising incidence of cancer and technological advancements in CT scanners to support market growth 167
7.5.3 NEUROLOGY 167
7.5.3.1 Increasing adoption of CT scanners for diagnosing various neurological conditions to drive market growth 167
7.5.4 OTHER APPLICATIONS 167
7.6 NUCLEAR IMAGING SYSTEMS 168
FIGURE 34 ONCOLOGY SEGMENT DOMINATE THE NUCLEAR IMAGING SYSTEMS MARKET, BY APPLICATION 168
TABLE 74 NUCLEAR IMAGING SYSTEMS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
7.6.1 ONCOLOGY 169
7.6.1.1 Nuclear imaging systems can distinguish between benign and malignant tumors, supporting precise diagnosis 169
7.6.2 CARDIOLOGY 169
7.6.2.1 The high prevalence of CVD is the major factor driving the growth of this segment 169
7.6.3 NEUROLOGY 169
7.6.3.1 The increasing demand for nuclear imaging procedures for diagnosing neurological disorders is supporting the growth of this segment 169
7.6.4 OTHER APPLICATIONS 170
7.7 MAMMOGRAPHY SYSTEMS 171
7.7.1 GROWING ADVANCEMENTS IN MAMMOGRAPHY TO SUPPORT THE GROWTH OF THIS SEGMENT 171
8 DIAGNOSTIC IMAGING MARKET, BY END USER 172
8.1 INTRODUCTION 173
TABLE 75 DIAGNOSTIC IMAGING MARKET, BY END USER, 2019–2026 (USD MILLION) 173
8.2 HOSPITALS 173
8.2.1 LARGE HOSPITALS HAVE BEEN EARLY ADOPTERS OF ADVANCED DIAGNOSTIC IMAGING SYSTEMS 173
TABLE 76 DIAGNOSTIC IMAGING MARKET FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION) 174
8.3 DIAGNOSTIC IMAGING CENTERS 174
8.3.1 THE INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO MARKET GROWTH 174
TABLE 77 DIAGNOSTIC IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS,
BY REGION, 2019–2026 (USD MILLION) 175
8.4 OTHER END USERS 176
TABLE 78 DIAGNOSTIC IMAGING MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION) 177
9 DIAGNOSTIC IMAGING MARKET, BY REGION 178
9.1 INTRODUCTION 179
FIGURE 35 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 179
TABLE 79 DIAGNOSTIC IMAGING MARKET, BY REGION, 2019–2026 (USD MILLION) 180
9.2 NORTH AMERICA 181
FIGURE 36 NORTH AMERICA: CANCER PREVALENCE, 2012–2020 181
FIGURE 37 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET SNAPSHOT 182
TABLE 80 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 183
TABLE 81 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 183
TABLE 82 NORTH AMERICA: CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 83 NORTH AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 84 NORTH AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 184
TABLE 85 NORTH AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 185
TABLE 86 NORTH AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 87 NORTH AMERICA: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 88 NORTH AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2019–2026 (USD MILLION) 186
TABLE 89 NORTH AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 186
TABLE 90 NORTH AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 187
TABLE 91 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 92 NORTH AMERICA: SPECT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 93 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY END USER,
2019–2026 (USD MILLION) 188
9.2.1 US 188
9.2.1.1 The US dominated the North American market in 2020 188
TABLE 94 US: KEY MACROINDICATORS 189
TABLE 95 US: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 189
TABLE 96 US: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 97 US: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 98 US: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 190
TABLE 99 US: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 191
TABLE 100 US: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 101 US: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 102 US: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 192
TABLE 103 US: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2019–2026 (USD MILLION) 192
TABLE 104 US: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 192
TABLE 105 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 106 US: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 193
9.2.2 CANADA 193
9.2.2.1 A shortage of radiologists and long wait times for scans are the major challenges in the Canadian market 193
TABLE 107 CANADA: KEY MACROINDICATORS 194
TABLE 108 CANADA: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 195
TABLE 109 CANADA: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 110 CANADA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 111 CANADA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 196
TABLE 112 CANADA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 196
TABLE 113 CANADA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 114 CANADA: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 115 CANADA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 197
TABLE 116 CANADA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 197
TABLE 117 CANADA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 198
TABLE 118 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 119 CANADA: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
9.3 ASIA PACIFIC 199
FIGURE 38 ASIA PACIFIC: CANCER PREVALENCE, 2012–2020 199
FIGURE 39 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET SNAPSHOT 200
TABLE 120 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 201
TABLE 121 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 201
TABLE 122 ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 202
TABLE 123 ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 202
TABLE 124 ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 202
TABLE 125 ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 203
TABLE 126 ASIA PACIFIC: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 127 ASIA PACIFIC: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 128 ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 129 ASIA PACIFIC: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 130 ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 204
TABLE 131 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 132 ASIA PACIFIC: SPECT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 133 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY END USER,
2019–2026 (USD MILLION) 205
9.3.1 JAPAN 206
9.3.1.1 Japan dominates the APAC market for diagnostic imaging 206
TABLE 134 JAPAN: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 207
TABLE 135 JAPAN: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 207
TABLE 136 JAPAN: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 207
TABLE 137 JAPAN: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 208
TABLE 138 JAPAN: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 208
TABLE 139 JAPAN: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 208
TABLE 140 JAPAN: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 209
TABLE 141 JAPAN: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 209
TABLE 142 JAPAN: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 143 JAPAN: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 144 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 145 JAPAN: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
9.3.2 CHINA 211
9.3.2.1 Government initiatives and the rapidly growing aging population to drive the growth of the market in China 211
TABLE 146 CHINA: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 211
TABLE 147 CHINA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 212
TABLE 148 CHINA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 212
TABLE 149 CHINA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 212
TABLE 150 CHINA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 213
TABLE 151 CHINA: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 152 CHINA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 213
TABLE 153 CHINA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 154 CHINA: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 155 CHINA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 214
TABLE 156 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 215
TABLE 157 CHINA: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
9.3.3 INDIA 215
9.3.3.1 Uncertainties in healthcare policies might restrict the growth of the Indian market 215
TABLE 158 INDIA: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 216
TABLE 159 INDIA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 216
TABLE 160 INDIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 217
TABLE 161 INDIA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 217
TABLE 162 INDIA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 217
TABLE 163 INDIA: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 218
TABLE 164 INDIA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 165 INDIA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 166 INDIA: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 167 INDIA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 219
TABLE 168 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 169 INDIA: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 220
9.3.4 SOUTH KOREA 220
9.3.4.1 Initiatives to increase access to imaging services in the country are expected to have a positive impact on the market growth 220
TABLE 170 SOUTH KOREA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 220
TABLE 171 SOUTH KOREA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 221
TABLE 172 SOUTH KOREA: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 221
TABLE 173 SOUTH KOREA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 222
TABLE 174 SOUTH KOREA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 222
TABLE 175 SOUTH KOREA: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 176 SOUTH KOREA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 223
TABLE 177 SOUTH KOREA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 223
TABLE 178 SOUTH KOREA: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 223
TABLE 179 SOUTH KOREA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 224
TABLE 180 SOUTH KOREA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 181 SOUTH KOREA: SPECT SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
9.3.5 AUSTRALIA 225
9.3.5.1 Supportive government initiatives in the country are the key factors supporting the market 225
TABLE 182 AUSTRALIA: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 225
TABLE 183 AUSTRALIA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 226
TABLE 184 AUSTRALIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 226
TABLE 185 AUSTRALIA: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 186 AUSTRALIA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 187 AUSTRALIA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 227
TABLE 188 AUSTRALIA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 227
TABLE 189 AUSTRALIA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 190 AUSTRALIA: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 191 AUSTRALIA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 228
TABLE 192 AUSTRALIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 193 AUSTRALIA: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
9.3.6 ROAPAC 229
TABLE 194 ROAPAC: DIAGNOSTIC IMAGING MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 195 ROAPAC: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2019–2026 (USD MILLION) 230
TABLE 196 ROAPAC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2019–2026 (USD MILLION) 231
TABLE 197 ROAPAC: CT SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 198 ROAPAC: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 199 ROAPAC: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 232
TABLE 200 ROAPAC: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 232
TABLE 201 ROAPAC: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 202 ROAPAC: DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 203 ROAPAC: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2019–2026 (USD MILLION) 233
TABLE 204 ROAPAC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 205 ROAPAC: SPECT SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION) 234

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127